Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells. [electronic resource]
- BMC cancer 03 2017
- 199 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2407
10.1186/s12885-017-3181-0 doi
Biomarkers, Tumor--genetics Biosensing Techniques Breast Neoplasms--diagnosis Drug Resistance, Neoplasm--genetics Female Gene Expression Regulation, Neoplastic Humans MCF-7 Cells Prognosis Receptor, ErbB-2--genetics